Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women

J Nutr. 2011 Oct;141(10):1827-33. doi: 10.3945/jn.111.139659. Epub 2011 Aug 24.

Abstract

The optimal amount of vegetable consumption required to reduce chronic disease risk is widely debated. Intervention trials evaluating biological activity of vegetables at various doses are limited. We conducted a 3-dose, crossover feeding trial to test the hypothesis that vegetable intake is associated in a dose-dependent manner with increased plasma carotenoids and subsequently reduced oxidative stress and inflammation in 49 overweight, postmenopausal women. Participants were assigned in random order to 2 (130 g), 5 (287 g), and 10 (614 g) daily servings of fresh, greenhouse-grown vegetables for 3-wk intervals with a 4-wk washout period between treatments. Plasma total carotenoids significantly increased from 1.63 to 2.07 μmol/L with a dose of 2 vegetable servings, from 1.49 to 2.84 μmol/L with a dose of 5 vegetable servings, and from 1.40 to 4.42 μmol/L with a dose of 10 vegetable servings (pre-post paired ttests, all P < 0.001). The change during each feeding period increased with each dose level (P < 0.001). Urine concentrations of 8-isoprostane F2α, hexanoyl lysine, and serum high sensitivity C-reactive protein were not affected by any administered vegetable dose. In this variable-dose vegetable study, a dose-response for plasma carotenoids was demonstrated without significant change in oxidative stress and inflammation in overweight, postmenopausal women.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Arizona / epidemiology
  • Biomarkers / blood
  • Biomarkers / urine
  • Body Mass Index
  • C-Reactive Protein / analysis
  • Carotenoids / blood*
  • Chronic Disease / epidemiology
  • Chronic Disease / prevention & control
  • Cross-Over Studies
  • Dinoprost / analogs & derivatives
  • Dinoprost / urine
  • Female
  • Humans
  • Lysine / urine
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy
  • Obesity / immunology*
  • Obesity / urine
  • Overweight / blood
  • Overweight / diet therapy
  • Overweight / immunology*
  • Overweight / urine
  • Oxidative Stress*
  • Postmenopause*
  • Risk Factors
  • Vegetables*

Substances

  • Biomarkers
  • N(epsilon)-hexanoyllysine
  • 8-epi-prostaglandin F2alpha
  • Carotenoids
  • C-Reactive Protein
  • Dinoprost
  • Lysine